Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71

Novel insights on proteins involved in Alzheimer’s disease (AD) are needed. Since multiple cell types and matrix components are altered in AD, bulk analysis of brain tissue maybe difficult to interpret. In the current study, we isolated pyramidal cells from the cornu ammonis 1 (CA1) region of the hi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna Sandebring-Matton, Michael Axenhus, Nenad Bogdanovic, Bengt Winblad, Sophia Schedin-Weiss, Per Nilsson, Lars O. Tjernberg
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/b8e169d732ac4e29afd84eac3f2589c9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b8e169d732ac4e29afd84eac3f2589c9
record_format dspace
spelling oai:doaj.org-article:b8e169d732ac4e29afd84eac3f2589c92021-11-19T16:14:56ZMicrodissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 711663-436510.3389/fnagi.2021.735334https://doaj.org/article/b8e169d732ac4e29afd84eac3f2589c92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnagi.2021.735334/fullhttps://doaj.org/toc/1663-4365Novel insights on proteins involved in Alzheimer’s disease (AD) are needed. Since multiple cell types and matrix components are altered in AD, bulk analysis of brain tissue maybe difficult to interpret. In the current study, we isolated pyramidal cells from the cornu ammonis 1 (CA1) region of the hippocampus from five AD and five neurologically healthy donors using laser capture microdissection (LCM). The samples were analyzed by proteomics using 18O-labeled internal standard and nano-high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) for relative quantification. Fold change between AD and control was calculated for the proteins that were identified in at least two individual proteomes from each group. From the 10 cases analyzed, 62 proteins were identified in at least two AD cases and two control cases. Creatine kinase B-type (CKB), 14-3-3-γ, and heat shock cognate 71 (Hsc71), which have not been extensively studied in the context of the human AD brain previously, were selected for further studies by immunohistochemistry (IHC). In hippocampus, semi-quantitative measures of IHC staining of the three proteins confirmed the findings from our proteomic analysis. Studies of the same proteins in the frontal cortex revealed that the alterations remained for CKB and 14-3-3-γ but not for Hsc71. Protein upregulation in CA1 neurons of final stage AD is either a result of detrimental, pathological effects, or from cell-specific protective response mechanisms in surviving neurons. Based on previous findings from experimental studies, CKB and Hsc71 likely exhibit protective effects, whereas 14-3-3-γ may represent a detrimental pathway. These new players could reflect pathways of importance for the development of new therapeutic strategies.Anna Sandebring-MattonAnna Sandebring-MattonAnna Sandebring-MattonMichael AxenhusMichael AxenhusNenad BogdanovicNenad BogdanovicBengt WinbladSophia Schedin-WeissPer NilssonLars O. TjernbergLars O. TjernbergFrontiers Media S.A.articleAlzheimer’s disease14-3-3-γcreatine kinase Bheat shock cognate 71laser capture microscopyproteomicsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Aging Neuroscience, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
14-3-3-γ
creatine kinase B
heat shock cognate 71
laser capture microscopy
proteomics
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Alzheimer’s disease
14-3-3-γ
creatine kinase B
heat shock cognate 71
laser capture microscopy
proteomics
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Anna Sandebring-Matton
Anna Sandebring-Matton
Anna Sandebring-Matton
Michael Axenhus
Michael Axenhus
Nenad Bogdanovic
Nenad Bogdanovic
Bengt Winblad
Sophia Schedin-Weiss
Per Nilsson
Lars O. Tjernberg
Lars O. Tjernberg
Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
description Novel insights on proteins involved in Alzheimer’s disease (AD) are needed. Since multiple cell types and matrix components are altered in AD, bulk analysis of brain tissue maybe difficult to interpret. In the current study, we isolated pyramidal cells from the cornu ammonis 1 (CA1) region of the hippocampus from five AD and five neurologically healthy donors using laser capture microdissection (LCM). The samples were analyzed by proteomics using 18O-labeled internal standard and nano-high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) for relative quantification. Fold change between AD and control was calculated for the proteins that were identified in at least two individual proteomes from each group. From the 10 cases analyzed, 62 proteins were identified in at least two AD cases and two control cases. Creatine kinase B-type (CKB), 14-3-3-γ, and heat shock cognate 71 (Hsc71), which have not been extensively studied in the context of the human AD brain previously, were selected for further studies by immunohistochemistry (IHC). In hippocampus, semi-quantitative measures of IHC staining of the three proteins confirmed the findings from our proteomic analysis. Studies of the same proteins in the frontal cortex revealed that the alterations remained for CKB and 14-3-3-γ but not for Hsc71. Protein upregulation in CA1 neurons of final stage AD is either a result of detrimental, pathological effects, or from cell-specific protective response mechanisms in surviving neurons. Based on previous findings from experimental studies, CKB and Hsc71 likely exhibit protective effects, whereas 14-3-3-γ may represent a detrimental pathway. These new players could reflect pathways of importance for the development of new therapeutic strategies.
format article
author Anna Sandebring-Matton
Anna Sandebring-Matton
Anna Sandebring-Matton
Michael Axenhus
Michael Axenhus
Nenad Bogdanovic
Nenad Bogdanovic
Bengt Winblad
Sophia Schedin-Weiss
Per Nilsson
Lars O. Tjernberg
Lars O. Tjernberg
author_facet Anna Sandebring-Matton
Anna Sandebring-Matton
Anna Sandebring-Matton
Michael Axenhus
Michael Axenhus
Nenad Bogdanovic
Nenad Bogdanovic
Bengt Winblad
Sophia Schedin-Weiss
Per Nilsson
Lars O. Tjernberg
Lars O. Tjernberg
author_sort Anna Sandebring-Matton
title Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
title_short Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
title_full Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
title_fullStr Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
title_full_unstemmed Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
title_sort microdissected pyramidal cell proteomics of alzheimer brain reveals alterations in creatine kinase b-type, 14-3-3-γ, and heat shock cognate 71
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/b8e169d732ac4e29afd84eac3f2589c9
work_keys_str_mv AT annasandebringmatton microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT annasandebringmatton microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT annasandebringmatton microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT michaelaxenhus microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT michaelaxenhus microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT nenadbogdanovic microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT nenadbogdanovic microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT bengtwinblad microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT sophiaschedinweiss microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT pernilsson microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT larsotjernberg microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
AT larsotjernberg microdissectedpyramidalcellproteomicsofalzheimerbrainrevealsalterationsincreatinekinasebtype1433gandheatshockcognate71
_version_ 1718420036299784192